Aurobindo Pharma
Indian multinational pharmaceutical company
Aurobindo Pharma ▸ Facts ▸ Comments ▸ News ▸ Videos
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.
| 0 shares | ShareTweetSavePostSend |
You Might Like
Delhi liquor 'scam': Kavitha threatened S C Reddy to pay money to AAP, CBI tells courtThe CBI disclosed that K Kavitha allegedly pressured Aurobindo Pharma promoter to pay Rs 25 crore to AAP for Delhi's excise zones, warning of business consequences. Kavitha is in CBI custody, accused..IndiaTimes - Published | |
Atishi questions ED probe, says Kejriwal arrested based on one person's accountDelhi minister Atishi Marlena of AAP alleged that CM Arvind Kejriwal's arrest stemmed from a statement by Aurobindo Pharma's owner, Sarath Chandra Reddy, who reportedly donated to BJP via electoral..IndiaTimes - Published | |
BJP, BRS & Cong top recipients of donations from pharma firmsBJP, BRS, Congress dominated pharma donations through electoral bonds, with BJP receiving the highest amount. Aurobindo Pharma, whose director was arrested in an excise scam, is also one of the donors..IndiaTimes - Published | |
Aurobindo gets USFDA nod for generic version of Nasonex nasal sprayIndiaTimes - Published | |
Aurobindo arm inks licence pact with Singapore's Hilleman for paediatric pentavalent vaccine candidateAurobindo Pharma's subsidiary, Auro Vaccines Pvt Ltd said it has signed a license agreement with Hilleman Laboratories Singapore to develop and commercialize a paediatric pentavalent vaccine candidate...IndiaTimes - Published | |
Aurobindo gets licence to make generic version of Pfizer's oral antiviral Covid-19 pill nirmatrelvirPharma major Aurobindo Pharma Limited has inked a sub-license agreement with the UN-backed Medicines Patent Pool (MPP) for manufacturing and supplying a generic version of Pfizer’s Covid-19 oral..IndiaTimes - Published | |
